Biogen Inc. buy Morgan Stanley
Start price
05.09.23
/
50%
€248.40
Target price
05.09.24
€355.70
Performance (%)
-27.13%
End price
06.09.24
€181.00
Summary
This prediction ended on 06.09.24 with a price of €181.00. The price of Biogen Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -27.13%. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | -4.751% | -4.751% | 3.814% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by Morgan_Stanley for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Morgan Stanley from $363.00 to $381.00. They now have an "overweight" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten